Financial Enhancement Group LLC Zoetis Inc. Transaction History

Financial Enhancement Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 18, 2022	BUY	$181.39 - $234.03 $2,176 - $2,808	12 Added 1200.0%	13 $2,000
Q2 2021 Aug 10, 2021	SELL	$155.9 - $187.99 $9,509 - $11,467	-61 Reduced 98.39%	1 $0
Q1 2021 May 10, 2021	SELL	$144.0 - $169.39 $9,360 - $11,010	-65 Reduced 51.18%	62 $10,000
Q2 2020 Aug 14, 2020	SELL	$111.92 - $142.53 $2,686 - $3,420	-24 Reduced 15.89%	127 $17,000
Q1 2020 May 04, 2020	SELL	$92.66 - $144.94 $463 - $724	-5 Reduced 3.21%	151 $18,000
Q1 2019 May 14, 2019	SELL	$81.56 - $100.67 $9,379 - $11,577	-115 Reduced 42.44%	156 $16,000
Q1 2018 Apr 30, 2018	BUY	$71.51 - $84.69 $19,379 - $22,950	271 New	271 $23,000

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Financial Enhancement Group LLC, based on Form 13F filings with the SEC.

Stay updated on Financial Enhancement Group LLC with notifications on news.